89bio, Inc. Total Liabilities and Equity
89bio, Inc. had Total Liabilities and Equity of $603.49 million as of 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2025-08-08
- 2025-06-30: Liabilities and Equity $603.49M.
- 2025-03-31: Liabilities and Equity $685.03M.
- 2024-12-31: Liabilities and Equity $478.69M.
- 2024-09-30: Liabilities and Equity $458.30M.
| Period end | Liabilities and Equity |
|---|---|
| 2025-06-30 | $603.49M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $685.03M 10-Q · filed 2025-05-02 |
| 2024-12-31 | $478.69M 10-Q · filed 2025-08-08 |
| 2024-09-30 | $458.30M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $582.14M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $577.32M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $596.27M 10-K · filed 2025-02-27 |
| 2023-09-30 | $460.11M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $492.51M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $494.32M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $196.82M 10-K · filed 2024-03-01 |
| 2022-09-30 | $200.58M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $147.59M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $135.76M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $162.42M 10-K · filed 2023-03-15 |
| 2021-09-30 | $168.06M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $181.71M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $198.65M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $211.07M 10-K · filed 2022-03-24 |
| 2020-09-30 | $223.43M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $76.56M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $87.69M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $95.55M 10-K · filed 2021-03-25 |
| 2019-09-30 | $18.35M 10-Q · filed 2019-12-18 |
| 2018-12-31 | $11.37M 10-K · filed 2020-03-18 |